These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9474010)

  • 21. Control of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus in hospitalized children.
    Fisher MC
    Pediatr Infect Dis J; 1998 Sep; 17(9):825-6. PubMed ID: 9779772
    [No Abstract]   [Full Text] [Related]  

  • 22. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
    [No Abstract]   [Full Text] [Related]  

  • 23. Emerging resistance in Enterococcus spp.
    Heath CH; Blackmore TK; Gordon DL
    Med J Aust; 1996 Jan; 164(2):116-20. PubMed ID: 8569563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening patients for glycopeptide-resistant enterococci.
    Chadwick PR; Elliot J; Rowland P; Keaney MG; Joseph LA
    J Hosp Infect; 1996 Jul; 33(3):226-8. PubMed ID: 8827510
    [No Abstract]   [Full Text] [Related]  

  • 25. Vancomycin-resistant enterococci in the pediatric patient.
    Bratcher DF
    Pediatr Infect Dis J; 2001 Jun; 20(6):621-2. PubMed ID: 11419507
    [No Abstract]   [Full Text] [Related]  

  • 26. Protecting your patients from VRE.
    Burns LA
    Am J Nurs; 1996 Aug; 96(8):23. PubMed ID: 8712235
    [No Abstract]   [Full Text] [Related]  

  • 27. Proficiency of clinical laboratories in and near Monterrey, Mexico, to detect vancomycin-resistant enterococci.
    McDonald LC; Garza LR; Jarvis WR
    Emerg Infect Dis; 1999; 5(1):143-6. PubMed ID: 10081682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic resistance. It's a bug's life.
    Siddall R
    Health Serv J; 2000 Nov; 110(5733):suppl 8-9. PubMed ID: 11138531
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre.
    Shaikh ZH; Osting CA; Hanna HA; Arbuckle RB; Tarr JJ; Raad II
    J Hosp Infect; 2002 May; 51(1):52-8. PubMed ID: 12009821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of transmission of vancomycin-resistant enterococci in three long-term-care facilities.
    Greenaway CA; Miller MA
    Infect Control Hosp Epidemiol; 1999 May; 20(5):341-3. PubMed ID: 10349951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients.
    Simonsen GS; Andersen BM; Digranes A; Harthug S; Jacobsen T; Lingaas E; Natås OB; Olsvik O; Ringertz SH; Skulberg A; Syversen G; Sundsfjord A
    Scand J Infect Dis; 1998; 30(5):465-8. PubMed ID: 10066045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three cases of resistant staph cause concern. The culprit: vancomycin misuse.
    Hosp Peer Rev; 1998 Feb; 23(2):24-5. PubMed ID: 10178212
    [No Abstract]   [Full Text] [Related]  

  • 33. Hospital superbugs. Physician, wash thyself, and other medical safety tips.
    Watson T
    US News World Rep; 1997 Feb; 122(6):64-6. PubMed ID: 10165090
    [No Abstract]   [Full Text] [Related]  

  • 34. [Vancomycin resistant enterococci in Austria].
    Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?
    Farr BM
    Clin Infect Dis; 2004 Apr; 38(8):1116-8. PubMed ID: 15095216
    [No Abstract]   [Full Text] [Related]  

  • 36. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
    Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enemy within. Basic weapons can foil VRE (vancomycin-resistant enterococcus).
    Pugliese G
    Mater Manag Health Care; 1997 Sep; 6(9):32, 34, 36-8. PubMed ID: 10173223
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit.
    Slaughter S; Hayden MK; Nathan C; Hu TC; Rice T; Van Voorhis J; Matushek M; Franklin C; Weinstein RA
    Ann Intern Med; 1996 Sep; 125(6):448-56. PubMed ID: 8779456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Keeping your patient safe from VRE.
    Borton D
    Nursing; 1995 May; 25(5):28. PubMed ID: 7746524
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vancomycin resistant enterococci].
    Fujita N; Komori T; Ike Y; Yoshimura M
    Rinsho Byori; 1998 Jul; 46(7):629-36. PubMed ID: 9721528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.